DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Inside Versiti's Data Strategy: Building AI-Ready Research Systems
Versiti’s Banu Santebennur explains how clean data, semantic layers, and cautious tech adoption prepare clinical research for AI.
-
How Versiti Turns Data Into A Lifeline For Rare Blood Patients
Versiti’s blood, diagnostic, and research teams show how a nonprofit uses technology to connect donors to the patients who need them most.
DCT TECHNOLOGY RESOURCES
-
The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.
-
Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.
-
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.
-
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
Digital health is proving to be much more than just a trendy fad—it’s a movement that is here to stay. So how can digital health improve patient engagement, and why is it important?